Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Key Questions For Dendreon
Forbes
Wednesday, March 2, 2011 - 10:32am
tags:
Dendreon, Provenge, vaccines, prostate cancer
Big Pharma To Continue Buying Up Solid Biotechs
Yahoo/InvestorsBusinessDaily
Wednesday, March 2, 2011 - 10:31am
tags:
Eli Lilly, Genzyme, M&A, Big Pharma, Sanofi
Amarin Sliding but With Prospects: Time to Buy?
Seeking Alpha
Wednesday, March 2, 2011 - 8:42am
tags:
Amarin
5 Major Pharmaceutical Companies With Bearish Warnings
Seeking Alpha
Wednesday, March 2, 2011 - 7:59am
tags:
Abbott Laboratories, Eli Lilly, Bristol-Myers Squibb, Novo Nordisk, Pfizer
Bristol-Myers Squibb Announces Dividend
Yahoo
Wednesday, March 2, 2011 - 7:53am
tags:
Bristol-Myers Squibb, dividends
Idenix’s loss widens on costs
Bizjournals.com
Tuesday, March 1, 2011 - 2:30pm
tags:
Idenix, earnings
Novavax Gets A Booster Shot From The Government
Investopedia
Tuesday, March 1, 2011 - 2:29pm
tags:
Novavax, federal government, vaccines
Abbott Tells Jurors Kaletra Was ‘Clobbered’ by Competitors
Bloomberg
Tuesday, March 1, 2011 - 2:28pm
tags:
Abbott Laboratories, Kaletra, HIV
Analyst Notes: Vivus delivers Qnexa update
Yahoo/AP
Tuesday, March 1, 2011 - 11:33am
tags:
Vivus, obesity, Qnexa
Bayer looks to JVs, not buys, for Indian growth
Fierce Pharma
Tuesday, March 1, 2011 - 11:06am
tags:
India, Bayer
Regulatory review delays completion of Merck, Sanofi animal health joint venture
Yahoo/AP
Tuesday, March 1, 2011 - 11:02am
tags:
Merck, animal health, Sanofi
Rigel reports narrower 4Q loss, costs fall
Yahoo/AP
Tuesday, March 1, 2011 - 11:01am
tags:
Rigel, earnings
Niche Opportunity May Be Slipping From Protalix's Grasp
Seeking Alpha
Tuesday, March 1, 2011 - 10:31am
tags:
Protalix BioTherapeutics, UPLYSO, Gaucher disease, Shire, Cerezyme, Genzyme, Vpriv
Battered but Unbroken Biotechs
Seeking Alpha
Tuesday, March 1, 2011 - 10:26am
tags:
Amylin, Alnylam, Celldex, Exelixis, Human Genome Sciences, Isis Pharmaceuticals, Lexicon Pharmaceuticals, Neurocrine, Nektar, ONYX Pharmaceuticals, Ziopharm, Seattle Genetics
5-Star Stocks Poised to Pop: Gilead Sciences
Motley Fool
Tuesday, March 1, 2011 - 10:18am
tags:
Gilead Sciences
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
Yahoo
Tuesday, March 1, 2011 - 10:16am
tags:
Pfizer, M&A, King
Philogen Says Research Unit Signed Accord With Pfizer
Bloomberg
Tuesday, March 1, 2011 - 10:15am
tags:
Pfizer, Philogen, drug discovery
Elan Pharmaceuticals pleads guilty in Zonegran case
Bizjournals.com
Tuesday, March 1, 2011 - 9:15am
tags:
Elan, Zonegran, lawsuits
Forest, Nycomed Win FDA Approval for Daliresp Lung Medicine
Bloomberg
Tuesday, March 1, 2011 - 9:13am
tags:
FDA, Daliresp, Forest Labs, Nycomed, COPD
Adolor Stock Catalysts for 2011 and 2012
Seeking Alpha
Tuesday, March 1, 2011 - 9:12am
tags:
Adolor

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.